Global Analgesics Market, By Drug Type (Prescription, Over the counter (OTC)), By Drug Class (Opioids, NSAID, Others), By Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal), By Pain Type (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns, Dental/Facial, Pediatric, Others), By Application (Internal, External), and opportunities and forecast 2020-2027
Analgesics Market Overview
Analgesics, also called painkillers, are medications that relieve different types of pain, from headaches to injuries to arthritis. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change the way the brain perceives pain. The global Analgesics market has been rising continuously due to the growing incidence of cancer and the increasing chronic diseases across the world. The increasing therapeutic benefits offered by analgesics, in addition to effective and fast relief from pain, have remarkably boosted the demand for analgesics in the years ahead. Additionally, the development of innovative drugs and increasing awareness about these treatment options have also significantly supported the growth of the Analgesics market.
Furthermore, rising recurring aches and pains due to growing the prevalence of cancer, cardiovascular disease, arthritis, and other chronic and acute diseases has fuelled the demand for analgesics. Additionally, the increasing prevalence of pain, the rising effective treatment options, a surge in the aging population, and the growing acceptance of analgesics by a larger target audience are some noteworthy factors positively impacting the growth of the global Analgesics market.
Covid-19 Impact on Analgesics Market
In addition, the current Analgesics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Analgesics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Analgesics Market Segment Overview
Based on Drug Type, Prescription analgesics currently represent the most popular drug type across the world. Based on the drug class, the Opioids segment dominates the market as they are extensively used in cancer pain management and end-stage diseases in which palliative care is required. In addition, Oral is the most common route of administration (ROA) since it is considered to be one of the safest ROA and requires minimal to no medical assistance. At present, musculoskeletal pain accounts for the maximum share of the global market. It is most often caused by an injury to the bones, joints, muscles, tendons, ligaments, or nerves. Currently, by application, the Internal segment exhibit a clear dominance in the market. They are intended for internal use and are either taken by mouth in the form of pills and liquids or inserted into the rectum in suppository form.
· Musculoskeletal · Surgical and Trauma · Cancer · Neuropathic · Migraine · Obstetrical · Fibromyalgia · Pain due to Burns · Dental/Facial · Pediatric · Others
Analgesics Market, By Application
· Internal · External
Analgesics Regional Overview
In terms of region, North America is at the forefront in the global Analgesics market and is predicted to continue to retain its lead position through the forecast period. New regulatory changes in the U.S., with new marketing strategies by analgesics companies, have significantly benefited this regional market. In addition to this, the increasing occurrence of aches and pains, the rise in the average age of the population, and an alarming rate of obesity are other factors propelling the growth of the market in this region. The European analgesics market is also estimated to expand in the coming years due to the rapid commercialization of new drugs and an increasingly old age population. The market of the Asia Pacific is projected to grow at the fastest rate in the forecast period. The analgesics market in developing countries, such as China and India, has many growth opportunities because of the availability of cheap raw materials and an economical workforce. Also, the global analgesics manufacturers are relocating their facilities into developing countries by agreements or acquisitions with local players.
Analgesics Market, By Geography
· North America (US & Canada) · Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe) · Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific) · LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Analgesics Market, Key Players
· Eli Lilly and Company · Teva Pharmaceutical Industries Ltd. · Bayer AG · F. Hoffmann-La Roche Ltd. · Pfizer Inc. · Endo Pharmaceuticals · Reckitt Benckiser plc · Bristol-Myers Squibb · Sanofi · Johnson & Johnson · Novartis AG · GlaxoSmithKline PLC
Analgesics Market Study Global Market Analysis, Insights and Forecast, 2020-2027
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1. Key Emerging Trends – For Major Countries
4.2. Latest Technological Advancement
4.3. Regulatory Landscape
4.4. Industry SWOT Analysis
4.5. Porters Five Forces Analysis
5. Global Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Drug Type
5.2.1. Prescription
5.2.2. Over the counter (OTC)
5.3. Market Analysis, Insights and Forecast – By Drug Class
5.3.1. Opioids
5.3.2. NSAID
5.3.3. Others
5.4. Market Analysis, Insights and Forecast – By Route of Administration
5.4.1. Oral
5.4.2. Parenteral
5.4.3. Topical
5.4.4. Transdermal
5.4.5. Rectal
5.5. Market Analysis, Insights and Forecast – By Pain Type
5.5.1. Musculoskeletal
5.5.2. Surgical and Trauma
5.5.3. Cancer
5.5.4. Neuropathic
5.5.5. Migraine
5.5.6. Obstetrical
5.5.7. Fibromyalgia
5.5.8. Pain due to Burns
5.5.9. Dental/Facial
5.5.10. Pediatric
5.5.11. Others
5.6. Market Analysis, Insights and Forecast – By Application
5.6.1. Internal
5.6.2. External
5.7. Market Analysis, Insights and Forecast – By Region
5.7.1. North America
5.7.2. Europe
5.7.3. Asia Pacific
5.7.4. Latin America, Middle East and Africa
6. North America Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Drug Type
6.2.1. Prescription
6.2.2. Over the counter (OTC)
6.3. Market Analysis, Insights and Forecast – By Drug Class
6.3.1. Opioids
6.3.2. NSAID
6.3.3. Others
6.4. Market Analysis, Insights and Forecast – By Route of Administration
6.4.1. Oral
6.4.2. Parenteral
6.4.3. Topical
6.4.4. Transdermal
6.4.5. Rectal
6.5. Market Analysis, Insights and Forecast – By Pain Type
6.5.1. Musculoskeletal
6.5.2. Surgical and Trauma
6.5.3. Cancer
6.5.4. Neuropathic
6.5.5. Migraine
6.5.6. Obstetrical
6.5.7. Fibromyalgia
6.5.8. Pain due to Burns
6.5.9. Dental/Facial
6.5.10. Pediatric
6.5.11. Others
6.6. Market Analysis, Insights and Forecast – By Application
6.6.1. Internal
6.6.2. External
6.7. Market Analysis, Insights and Forecast – By Country
6.7.1. U.S.
6.7.2. Canada
7. Europe Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Drug Type
7.2.1. Prescription
7.2.2. Over the counter (OTC)
7.3. Market Analysis, Insights and Forecast – By Drug Class
7.3.1. Opioids
7.3.2. NSAID
7.3.3. Others
7.4. Market Analysis, Insights and Forecast – By Route of Administration
7.4.1. Oral
7.4.2. Parenteral
7.4.3. Topical
7.4.4. Transdermal
7.4.5. Rectal
7.5. Market Analysis, Insights and Forecast – By Pain Type
7.5.1. Musculoskeletal
7.5.2. Surgical and Trauma
7.5.3. Cancer
7.5.4. Neuropathic
7.5.5. Migraine
7.5.6. Obstetrical
7.5.7. Fibromyalgia
7.5.8. Pain due to Burns
7.5.9. Dental/Facial
7.5.10. Pediatric
7.5.11. Others
7.6. Market Analysis, Insights and Forecast – By Application
7.6.1. Internal
7.6.2. External
7.7. Market Analysis, Insights and Forecast – By Country
7.7.1. UK
7.7.2. Germany
7.7.3. France
7.7.4. Italy
7.7.5. Spain
7.7.6. Russia
7.7.7. Rest of Europe
8. Asia Pacific Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Drug Type
8.2.1. Prescription
8.2.2. Over the counter (OTC)
8.3. Market Analysis, Insights and Forecast – By Drug Class
8.3.1. Opioids
8.3.2. NSAID
8.3.3. Others
8.4. Market Analysis, Insights and Forecast – By Route of Administration
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
8.4.4. Transdermal
8.4.5. Rectal
8.5. Market Analysis, Insights and Forecast – By Pain Type
8.5.1. Musculoskeletal
8.5.2. Surgical and Trauma
8.5.3. Cancer
8.5.4. Neuropathic
8.5.5. Migraine
8.5.6. Obstetrical
8.5.7. Fibromyalgia
8.5.8. Pain due to Burns
8.5.9. Dental/Facial
8.5.10. Pediatric
8.5.11. Others
8.6. Market Analysis, Insights and Forecast – By Application
8.6.1. Internal
8.6.2. External
8.7. Market Analysis, Insights and Forecast – By Country
8.7.1. China
8.7.2. India
8.7.3. Japan
8.7.4. Australia
8.7.5. South East Asia
8.7.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Analgesics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
9.1. Key Findings / Summary
9.2. Market Analysis, Insights and Forecast – By Drug Type
9.2.1. Prescription
9.2.2. Over the counter (OTC)
9.3. Market Analysis, Insights and Forecast – By Drug Class
9.3.1. Opioids
9.3.2. NSAID
9.3.3. Others
9.4. Market Analysis, Insights and Forecast – By Route of Administration
9.4.1. Oral
9.4.2. Parenteral
9.4.3. Topical
9.4.4. Transdermal
9.4.5. Rectal
9.5. Market Analysis, Insights and Forecast – By Pain Type
9.5.1. Musculoskeletal
9.5.2. Surgical and Trauma
9.5.3. Cancer
9.5.4. Neuropathic
9.5.5. Migraine
9.5.6. Obstetrical
9.5.7. Fibromyalgia
9.5.8. Pain due to Burns
9.5.9. Dental/Facial
9.5.10. Pediatric
9.5.11. Others
9.6. Market Analysis, Insights and Forecast – By Application
9.6.1. Internal
9.6.2. External
9.7. Market Analysis, Insights and Forecast – By Country
9.7.1. Brazil
9.7.2. Saudi Arabia
9.7.3. UAE
9.7.4. Rest of LAMEA
10. Competitive Analysis
10.1. Company Market Share Analysis, 2018
10.2. Key Industry Developments
10.3. Company Profile
10.4. Eli Lilly and Company
10.4.1. Business Overview
10.4.2. Segment 1 & Service Offering
10.4.3. Overall Revenue
10.4.4. Geographic Presence
10.4.5. Recent Development
*Similar details will be provided for the following companies
10.5. Teva Pharmaceutical Industries Ltd.
10.6. Bayer AG
10.7. F. Hoffmann-La Roche Ltd.
10.8. Pfizer Inc.
10.9. Endo Pharmaceuticals
10.10. Reckitt Benckiser plc
10.11. Bristol-Myers Squibb
10.12. Sanofi
10.13. Johnson & Johnson
10.14. Novartis AG
List of Figures
Figure 1: Global Analgesics Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Analgesics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Analgesics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Analgesics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Analgesics Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Analgesics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Analgesics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Analgesics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Analgesics Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Analgesics Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Analgesics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Analgesics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Analgesics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Analgesics Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Analgesics Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Analgesics Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Analgesics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Analgesics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Analgesics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Analgesics Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Analgesics Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Analgesics Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Analgesics Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Analgesics Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Analgesics Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Analgesics Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Analgesics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Analgesics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Analgesics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Analgesics Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Analgesics Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Analgesics Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Analgesics Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Analgesics Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Analgesics Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Analgesics Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Analgesics Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Analgesics Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Analgesics Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Analgesics Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Analgesics Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Analgesics Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Analgesics Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Analgesics Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Analgesics Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Analgesics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Analgesics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Analgesics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Analgesics Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Analgesics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Analgesics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Analgesics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Analgesics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Analgesics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Analgesics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Analgesics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Analgesics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Analgesics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Analgesics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Analgesics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Analgesics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Analgesics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Analgesics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Analgesics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Analgesics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Analgesics Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Analgesics Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Analgesics Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Analgesics Market Revenue (USD Billion) Forecast, by Country, 2016-2027
